Chromosome 11q13 amplification correlates with poor response and prognosis to PD-1 blockade in unresectable hepatocellular carcinoma

BACKGROUND & AIMS: Little is known about molecular biomarkers that predict the response and prognosis in unresectable hepatocellular carcinoma (HCC) treated with programmed death (PD)-1 inhibitors. METHODS: A total of 62 HCC patients who underwent next-generation sequencing were retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Kai, Zhang, Ding, Chen, Yanan, Lu, Wenfeng, Huang, Mengli, Cai, Jinping, Chen, Shiqing, Bei, Ting, Bai, Yuezong, Lv, Jian, Fu, Yong, Zhang, Haibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086239/
https://www.ncbi.nlm.nih.gov/pubmed/37056769
http://dx.doi.org/10.3389/fimmu.2023.1116057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086239/
https://www.ncbi.nlm.nih.gov/pubmed/37056769
http://dx.doi.org/10.3389/fimmu.2023.1116057

Ejemplares similares